Back to Search
Start Over
Protective role of serpina3c as a novel thrombin inhibitor against atherosclerosis in mice.
- Source :
-
Clinical science (London, England : 1979) [Clin Sci (Lond)] 2021 Feb 12; Vol. 135 (3), pp. 447-463. - Publication Year :
- 2021
-
Abstract
- Abnormal vascular smooth muscle cell (VSMC) proliferation is a critical step in the development of atherosclerosis. Serpina3c is a serine protease inhibitor (serpin) that plays a key role in metabolic diseases. The present study aimed to investigate the role of serpina3c in atherosclerosis and regulation of VSMC proliferation and possible mechanisms. Serpina3c is down-regulated during high-fat diet (HFD)-induced atherosclerosis. An Apoe-/-/serpina3c-/--double-knockout mouse model was used to determine the role of serpina3c in atherosclerosis after HFD for 12 weeks. Compared with Apoe-/- mice, the Apoe-/-/serpina3c-/- mice developed more severe atherosclerosis, and the number of VSMCs and macrophages in aortic plaques was significantly increased. The present study revealed serpina3c as a novel thrombin inhibitor that suppressed thrombin activity. In circulating plasma, thrombin activity was high in the Apoe-/-/serpina3c-/- mice, compared with Apoe-/- mice. Immunofluorescence staining showed thrombin and serpina3c colocalization in the liver and aortic cusp. In addition, inhibition of thrombin by dabigatran in serpina3c-/- mice reduced neointima lesion formation due to partial carotid artery ligation. Moreover, an in vitro study confirmed that thrombin activity was also decreased by serpina3c protein, supernatant and cell lysate that overexpressed serpina3c. The results of experiments showed that serpina3c negatively regulated VSMC proliferation in culture. The possible mechanism may involve serpina3c inhibition of ERK1/2 and JNK signaling in thrombin/PAR-1 system-mediated VSMC proliferation. Our results highlight a protective role for serpina3c as a novel thrombin inhibitor in the development of atherosclerosis, with serpina3c conferring protection through the thrombin/PAR-1 system to negatively regulate VSMC proliferation through ERK1/2 and JNK signaling.<br /> (© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.)
- Subjects :
- Animals
Antithrombins pharmacology
Aorta
Apolipoproteins E deficiency
Atherosclerosis pathology
Cells, Cultured
Dabigatran pharmacology
Diet, High-Fat
Male
Mice, Inbred C57BL
Mice, Knockout
Neointima
Plaque, Atherosclerotic metabolism
Serpins genetics
Signal Transduction
Mice
Atherosclerosis metabolism
Serpins pharmacology
Thrombin drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1470-8736
- Volume :
- 135
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical science (London, England : 1979)
- Publication Type :
- Academic Journal
- Accession number :
- 33458764
- Full Text :
- https://doi.org/10.1042/CS20201235